Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Stelara

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
  • Elie Dolgin
  • Nature Biotechnology
  • 2016
  • Corpus ID: 205273437
Newly released data from the first drug to exclusively inhibit the pro-inflammatory cytokine interleukin-23 (IL-23) show similar… Expand
  • table 1
Is this relevant?
2014
2014
it tried to show that Janssen’s Stelara (ustekinumab) — an antibody binding to interleukin‐12 (IL‐12) and IL‐23 that is marketed… Expand
Is this relevant?
2013
2013
Vortioxetine (Brintellix) for major depressive disorder; ustekinumab (stelara) for psoriatic arthritis; and dabrafenib mesylate… Expand
Is this relevant?
2010
2010
  • The Medical letter on drugs and therapeutics
  • 2010
  • Corpus ID: 35910613
 
Is this relevant?
2009
2009
New biologic: Ustekinumab (Stelara) was approved on September 25, 2009, for the treatment of adult patients aged 18 years or… Expand
Is this relevant?
Review
2008
Review
2008
Later this month, the US Food and Drug Administration (FDA) will decide whether a new psoriasis drug, Stelara (ustekinumab), can… Expand
  • figure 1
Is this relevant?
Review
2008
Review
2008
Later this month, the US Food and Drug Administration (FDA) will decide whether a new psoriasis drug, Stelara (ustekinumab), can… Expand
  • figure 1
  • table 1
Is this relevant?